EP0420930A4 - Method of synthesis and novel compounds for pharmaceutical uses - Google Patents

Method of synthesis and novel compounds for pharmaceutical uses

Info

Publication number
EP0420930A4
EP0420930A4 EP19890907939 EP89907939A EP0420930A4 EP 0420930 A4 EP0420930 A4 EP 0420930A4 EP 19890907939 EP19890907939 EP 19890907939 EP 89907939 A EP89907939 A EP 89907939A EP 0420930 A4 EP0420930 A4 EP 0420930A4
Authority
EP
European Patent Office
Prior art keywords
synthesis
novel compounds
pharmaceutical uses
pharmaceutical
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19890907939
Other versions
EP0420930A1 (en
Inventor
Iraj Lalezari
Parviz Lalezari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0420930A1 publication Critical patent/EP0420930A1/en
Publication of EP0420930A4 publication Critical patent/EP0420930A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • C07C273/1809—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety
    • C07C273/1818—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety from -N=C=O and XNR'R"
    • C07C273/1827—X being H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/75—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP19890907939 1988-06-15 1989-06-15 Method of synthesis and novel compounds for pharmaceutical uses Withdrawn EP0420930A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US207098 1988-06-15
US07/207,098 US4921997A (en) 1988-06-15 1988-06-15 Method of synthesis and novel compounds for pharmaceutical uses

Publications (2)

Publication Number Publication Date
EP0420930A1 EP0420930A1 (en) 1991-04-10
EP0420930A4 true EP0420930A4 (en) 1991-12-04

Family

ID=22769196

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19890907939 Withdrawn EP0420930A4 (en) 1988-06-15 1989-06-15 Method of synthesis and novel compounds for pharmaceutical uses

Country Status (4)

Country Link
US (1) US4921997A (en)
EP (1) EP0420930A4 (en)
JP (1) JPH03505728A (en)
WO (1) WO1989012622A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268500A (en) * 1987-06-15 1993-12-07 Montefiore Medical Center Compound, composition and method for the reduction of lipids the modification of the affinity of hemoblogin for oxygen and the prevention of platelet aggregation
US5093367A (en) * 1988-06-15 1992-03-03 Montefiore Medical Center Method of synthesis and novel compounds for pharmaceutical uses
US5382680A (en) * 1990-12-07 1995-01-17 The Center For Innovative Technology Allosteric hemoglobin modifier compounds
US5648375A (en) * 1990-02-12 1997-07-15 Virginia Commonwealth University Use of hydrophobic compounds and anesthetics in combination with allosteric hemoglobin modifiers
US5049695A (en) * 1990-02-12 1991-09-17 Center For Innovative Technology Allosteric hemoglobin modifiers
GB9027023D0 (en) * 1990-12-12 1991-01-30 Wellcome Found Anti-atherosclerotic aryl compounds
EP0641770B1 (en) * 1993-03-17 1998-05-13 Meiji Seika Kabushiki Kaisha Novel compound with platelet aggregation inhibitor activity
US5525630A (en) * 1995-06-01 1996-06-11 Allos Therapeutics, Inc. Treatment for carbon monoxide poisoning
US6696475B2 (en) 1997-04-22 2004-02-24 Neurosearch A/S Substituted phenyl derivatives, their preparation and use
NZ510098A (en) 1998-10-22 2003-09-26 Neurosearch As Substituted phenyl derivatives, pharmaceuticals thereof and their use as blockers of the chloride channel
CA2368688C (en) 1999-04-05 2009-08-11 City Of Hope Novel inhibitors of formation of advanced glycation endproducts (age's)
US7030133B2 (en) * 1999-04-05 2006-04-18 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGEs)
US6605642B2 (en) 1999-04-05 2003-08-12 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGES)
WO2000066102A2 (en) 1999-04-29 2000-11-09 City Of Hope Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
AU6912500A (en) * 1999-08-25 2001-03-19 Gmp Companies, Inc. Enhanced oxygen delivery in mammals, methods and reagents related thereto
JP4976851B2 (en) 2003-10-27 2012-07-18 シティ・オブ・ホープ Methods for reducing lipid levels in mammals
US8580854B2 (en) * 2005-11-09 2013-11-12 City Of Hope Methods of suppression of rage gene expression and rage triggered inflammatory genes by selected age-inhibitors
TW200900072A (en) * 2007-03-22 2009-01-01 Arete Therapeutics Inc Soluble epoxide hydrolase inhibitors
US8124655B2 (en) * 2007-06-15 2012-02-28 City Of Hope Use of LR-90 and LR-102 to overcome insulin resistance
CN115583890B (en) * 2022-10-13 2023-06-06 黑龙江中医药大学 Medicament for treating dyslipidemia and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1571198A (en) * 1967-06-28 1969-06-13
WO1988010113A1 (en) * 1987-06-15 1988-12-29 Iraj Lalezari Compound, composition and method for the reduction of lipids the modification of the affinity of hemoglobin for oxygen and the prevention of platelet aggregation
EP0358118A1 (en) * 1988-09-03 1990-03-14 Roche Diagnostics GmbH Phenylamides - process for their preparation as well as a drug containing those compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3020145A (en) * 1955-12-22 1962-02-06 Du Pont Herbicidal composition and method employing substituted ureas
DE2614045A1 (en) * 1976-04-01 1977-10-06 Boehringer Mannheim Gmbh Hypolipaemic ureido-alkyl-phenoxy-alkanoic aid derivs. prepn. - by reacting (4)-hydroxy-aralkylamines with phosgene, amine and halo-alkanoic acid deriv.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1571198A (en) * 1967-06-28 1969-06-13
WO1988010113A1 (en) * 1987-06-15 1988-12-29 Iraj Lalezari Compound, composition and method for the reduction of lipids the modification of the affinity of hemoglobin for oxygen and the prevention of platelet aggregation
EP0358118A1 (en) * 1988-09-03 1990-03-14 Roche Diagnostics GmbH Phenylamides - process for their preparation as well as a drug containing those compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 85, no. 16, August 1988, pages 6117-6121; I. LALEZARI et al.: "LR16, a compound with potent effects on the oxygen affinity of hemoglobin, on blood cholesterol, and on low density lipoprotein" *
See also references of WO8912622A1 *

Also Published As

Publication number Publication date
WO1989012622A1 (en) 1989-12-28
US4921997A (en) 1990-05-01
JPH03505728A (en) 1991-12-12
EP0420930A1 (en) 1991-04-10

Similar Documents

Publication Publication Date Title
HUT49316A (en) Process for producing didehydro-d3-vitamine derivatives and pharmaceutical compositions containing them
HUT48900A (en) Process for producing phosphoruus-containing squalene-synthetase inhibitores and pharmaceutical compositions containing them
AU4418789A (en) Synthesis of camptothecin and analogs thereof
EP0420930A4 (en) Method of synthesis and novel compounds for pharmaceutical uses
HUT51613A (en) Process for producing piperidinyl-benzimidazole derivatives and pharmaceutical compositions containing these compounds
HUT41790A (en) Process for producing beta-amino-purine derivatives and pharmaceutical compositions containing them
LTIP1660A (en) Method for preparating of pharmaceutical composition
HU904169D0 (en) Process for producing new hetrazepines of paf-antagonistic effect and pharmaceutical preparations containing these compounds
RU1833360C (en) Method of $$$-aldehydes synthesis
HUT53885A (en) Process for producing piridazinon derivatives of 2-hydroxy-n-propyl-amines and pharmaceutical compositions containing them
HUT48887A (en) Process for producing cyclopentenyl-purin derivatives and pharmaceutical compositions containing them
HUT44512A (en) Process for producing bensyl derivatives and pharmaceutical compositions containing them
HUT56098A (en) Process for producing azanaphtalenesultame derivatives and pharmaceutical compositions containing them
EP0331524A3 (en) Synthesis of trichostatins
HUT59908A (en) Process for producing benzazepine- and benzo-thiazepine derivatives and pharmaceutical compositions containing them
HU903196D0 (en) Process for producing benzocycloalkane derivatives and pharmaceutical preparatives containing these compounds
HUT49317A (en) Process for producing 16-dehydro-d3-vitamine derivatives and pharmaceutical compositions containing them
HU896774D0 (en) Process for preparation of condensated-quinoline-derivatives
HUT42478A (en) Process for producing gamma-carboline derivatives and pharmaceutical compositions containing them
HU896728D0 (en) Process for preparation of mono-n-alkylated polyzamacrocyclides
HUT41035A (en) Process for producing cepheme derivatives and pharmaceutical compositions containing them
HUT56342A (en) Process for producing capsoicin derivatives and pharmaceutical compositions comprising such compounds
YU236989A (en) Derivatives of 2-iminobenzothiazoline and process for obtaining thereof
GB8804372D0 (en) Synthesis of dihydroqinghaosu derivatives
HUT58739A (en) Process for producing 3-oxo-3-/benzopyrano- or -thiopyrano-pyrazol-3-yl/-propionitril derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19901212

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19911015

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19930414

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19930825